Frank Boeckler

University Professor (W3) for Medicinal Chemistry / Drug Design

Eberhard Karls Universität Tübingen

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biochemistry

80%

Pharmaceutical Chemistry

60%

Protein Chemistry

50%

Molecular Biology

30%

Ligand Design

30%

Molecular Modeling

30%

Chemical Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles13

Halogen Bonding on Water─A Drop in the Ocean?

Article Link

Year:

2024

Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53

Article Link

Year:

2024

Principles and Applications of CF2X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug Discovery

Article Link

Year:

2023

Statistical Analysis in Clinical and Experimental Medical Research: Simplified Guidance for Authors and Reviewers

Article Link

Year:

2023

Synthesis of Amino Acids Bearing Halodifluoromethyl Moieties and Their Application to p53-Derived Peptides Binding to Mdm2/Mdm4

Article Link

Year:

2023

In Silico Targeting of Fascin Protein for Cancer Therapy: Benchmarking, Virtual Screening and Molecular Dynamics Approaches

Article Link

Year:

2023

Discovery of Ircinianin Lactones B and C—Two New Cyclic Sesterterpenes from the Marine Sponge Ircinia wistarii

Article Link

Year:

2022

Screening of a Halogen-Enriched Fragment Library Leads to Unconventional Binding Modes

Article Link

Year:

2022

Quadruple Target Evaluation of Diversity-Optimized Halogen-Enriched Fragments (HEFLibs) Reveals Substantial Ligand Efficiency for AP2-Associated Protein Kinase 1 (AAK1)

Article Link

Year:

2022

Revisiting a challenging p53 binding site: a diversity-optimized HEFLib reveals diverse binding modes in T-p53C-Y220C

Article Link

Year:

2022

Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization

Article Link

Year:

2021

Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking

Article Link

Year:

2021

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking.

Article Link

Year:

2020

Collaborators8

Patrick Cahill

Cawthron Institute

NEW ZEALAND

Michael Schindler

University Hospital Tübingen

GERMANY

Michael Laemmerhofer

Prof

Eberhard Karls Universität Tübingen

GERMANY

Marc Hübner

Professor for Translational Microbiology

University Hospital Bonn

GERMANY

Harald Gross

Full Professor (W3) for Pharmaceutical Biology

Eberhard Karls Universität Tübingen

GERMANY

Matthias Gehringer

Eberhard Karls Universität Tübingen

GERMANY

Georgios Panos

Honorary Assistant Professor

University of Nottingham

UNITED KINGDOM

Antti Poso

Professor at University of Eastern Finland

University of Eastern Finland

FINLAND

How do I reach out?

Meet Kite AI